Real-world safety and effectiveness outcomes of Venetoclax monotherapy in patients with relapsed/refractory CLL, who did not match key inclusion criteria of pivotal clinical trials - Results from the non-interventional study VeRVe
ONCOLOGY RESEARCH AND TREATMENT（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要